Genetic analysis of multiple sclerosis.

被引:31
作者
Compston A. [1 ]
Sawcer S. [1 ]
机构
[1] University of Cambridge Neurology Unit, Addenbrooke's Hospital, Hills Road
关键词
Multiple Sclerosis; Linkage Disequilibrium; Major Histocompatibility Complex; Human Leukocyte Antigen; Human Leukocyte Antigen Class;
D O I
10.1007/s11910-002-0085-3
中图分类号
学科分类号
摘要
The increased recurrence risk within families indicates a role for genetic factors in the etiology of multiple sclerosis. Genes may influence susceptibility to the development of multiple sclerosis and the subsequent course of the disease. To date, associations have only been demonstrated consistently with class II major histocompatibility complex (MHC) alleles. The relatively low yield from additional candidate gene studies is only modestly advanced by several whole-genome linkage analyses, and by the first in a series of planned whole-genome linkage disequilibrium screens for allelic associations. The aims of linkage and association are to narrow the search for chromosomal regions encoding genes for multiple sclerosis and, with information from the human gene project, suggest new positional candidates. In time, it is expected that these genes will include some that confer susceptibility to the general process of autoimmunity, others that are specific for multiple sclerosis in all populations, some that act only in defined ethic groups, and those that determine particular phenotypes or shape the clinical course. These genetic analyses are predicated on the assumption that multiple sclerosis is one disease; a major part of future studies will be to resolve the question of disease heterogeneity in multiple sclerosis. When eventually in place, the potential of this genetic knowledge for improved understanding of the pathogenesis of multiple sclerosis and designing novel treatments is considerable.
引用
收藏
页码:259 / 266
页数:7
相关论文
共 50 条
  • [41] Vitamin D and multiple sclerosis. Prevalence of hypovitaminosis D
    Lopez Mendez, P.
    Sosa Henriquez, M.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2015, 7 (02) : 71 - 78
  • [42] The complex genetic aetiology of multiple sclerosis
    Oksenberg, JR
    Barcellos, LF
    JOURNAL OF NEUROVIROLOGY, 2000, 6 : S10 - S14
  • [43] Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives
    Pöllmann W.
    Busch C.
    Voltz R.
    Der Nervenarzt, 2005, 76 (2) : 154 - 169
  • [44] Multiple sclerosis. Part 2: Ophthalmic issues in MS therapy
    Pula, John H.
    Javed, Adil
    CURRENT OPINION IN OPHTHALMOLOGY, 2009, 20 (06) : 476 - 481
  • [45] Urinary disorders in multiple sclerosis. Two clinical case reports
    R. Nardulli
    E. Losavio
    Neurological Sciences, 2006, 27 : s328 - s330
  • [46] Current concepts on the use of immunomodulatory drugs in the treatment of multiple sclerosis.
    Correale, J
    Cristiano, E
    MEDICINA-BUENOS AIRES, 2001, 61 (04) : 470 - 480
  • [47] Fatigue in neurological disease: different patterns in stroke and multiple sclerosis.
    Gramigna, S.
    Schluep, M.
    Staub, F.
    Bruggimann, L.
    Simioni, S.
    Bogousslavsky, J.
    Annoni, J. M.
    REVUE NEUROLOGIQUE, 2007, 163 (03) : 341 - 348
  • [48] DEPRESSION AND ANXIETY IN PATIENTS WITH MULTIPLE SCLEROSIS. COMPARISON WITH GRADE OF DISABILITY
    Ignatova, Valentina
    Todorova, Lyudmila
    Stoyanova, Tsvetanka
    Haralanov, Lyubomir
    Surchev, Jivko
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2019, 72 (10): : 1433 - 1440
  • [49] Escalating immunomodulatory therapy of multiple sclerosis.: Update (September 2006)
    Bassetti, C.
    Beer, K.
    Beer, S.
    Buettner, U.
    Chofflon, M.
    Gass, A.
    Goebels, N.
    Goetschi-Fuchs, M.
    Kappos, L.
    Kesselring, J.
    Ludin, H. -P.
    Mattle, H.
    Schluep, M.
    Vaney, C.
    Baumhackl, U.
    Berger, T.
    Deisenhammer, F.
    Fazekas, F.
    Freimueller, M.
    Kollegger, H.
    Kristoferitsch, W.
    Lassmann, H.
    Markut, H.
    Strasser-Fuchs, S.
    Vass, K.
    Altenkirch, H.
    Bamborschke, S.
    Baum, K.
    Bayas, A.
    Benecke, R.
    Brueck, W.
    Buttmann, M.
    Chan, A.
    Daumer, M.
    Dommasch, D.
    Elias, W. G.
    Fasshauer, E.
    Flachenecker, P.
    Gehlen, W.
    Gold, R.
    Haas, J.
    Haferkamp, G.
    Haller, P.
    Hartung, H. -P.
    Heesen, C.
    Heibel, M.
    Heidenreich, F.
    Hemmer, B.
    Henze, T.
    Hohlfeld, R.
    NERVENARZT, 2006, 77 (12): : 1506 - 1518
  • [50] Epileptic seizures in patients with multiple sclerosis. Is the prognosis of epilepsy underestimated
    Engelsen, BA
    Gronning, M
    SEIZURE, 1997, 6 (05) : 377 - 382